
- 积分
- 57
- 威望
- 57
- 包包
- 665
|

回复 sarah19860420 的帖子7 C( G, q( t1 S6 ~5 ?
+ b) w* h7 Y n/ m/ r% ?3 V
抱歉,我这儿也没有全文 把摘要贴给你看一下~ 希望你权限大一些能下来全文 呵呵
5 }' @1 a3 m9 s- f, EGenomic alterations in cultured human embryonic stem cells.
: j: b/ k5 }( _* m8 q2 _" ]# OMaitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, Sui G, Cutler DJ, Liu Y, Brimble SN, Noaksson K, Hyllner J, Schulz TC, Zeng X, Freed WJ, Crook J, Abraham S, Colman A, Sartipy P, Matsui S, Carpenter M, Gazdar AF, Rao M, Chakravarti A.
4 ^ Q8 d. M, D/ b8 ASourceMcKusick-Nathans Institute of Genetic Medicine, Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.' H7 ^6 L! l' [( S9 h
6 n8 m# s6 j9 y$ dAbstract6 J+ W5 H3 I9 q2 I5 k+ F. U* b) B
Cultured human embryonic stem cell (hESC) lines are an invaluable resource because they provide a uniform and stable genetic system for functional analyses and therapeutic applications. Nevertheless, these dividing cells, like other cells, probably undergo spontaneous mutation at a rate of 10(-9) per nucleotide. Because each mutant has only a few progeny, the overall biological properties of the cell culture are not altered unless a mutation provides a survival or growth advantage. Clonal evolution that leads to emergence of a dominant mutant genotype may potentially affect cellular phenotype as well. We assessed the genomic fidelity of paired early- and late-passage hESC lines in the course of tissue culture. Relative to early-passage lines, eight of nine late-passage hESC lines had one or more genomic alterations commonly observed in human cancers, including aberrations in copy number (45%), mitochondrial DNA sequence (22%) and gene promoter methylation (90%), although the latter was essentially restricted to 2 of 14 promoters examined. The observation that hESC lines maintained in vitro develop genetic and epigenetic alterations implies that periodic monitoring of these lines will be required before they are used in in vivo applications and that some late-passage hESC lines may be unusable for therapeutic purposes.
0 O/ c3 D; o4 \& E0 }9 {' ]! Q0 R9 d- `, z* P6 F( ~* d0 P$ J
|
-
总评分: 威望 + 2
包包 + 10
查看全部评分
|